Biochemical bone markers in nephrotic children
- 17 June 2004
- journal article
- research article
- Published by Springer Nature in Pediatric Nephrology
- Vol. 19 (8) , 869-873
Abstract
In this study we evaluated the effects of high-dose corticosteroid (CS) therapy and the character of the nephrotic syndrome (NS) itself on bones in patients with normal glomerular filtration rate. We measured serum osteocalcin (OC), alkaline phosphatase (ALP), intact parathyroid hormone (iPTH), 25-hydroxyvitamin D, calcium (Ca), phosphorus (P), and magnesium (Mg) levels, and urinary Ca and protein excretion in nephrotic children during the active phase before (group Ia) and after CS treatment (group Ib). The results were compared with age-matched control subjects. A significant increase in urinary Ca excretion was observed after CS treatment. Serum ALP, OC, and iPTH levels were within normal limits at the time of study entry. However, both serum OC and ALP levels showed a significant decrease after the completion of CS treatment (OC from 13.6±9.2 ng/ml to 6.7±5.2 ng/ml and ALP from 151.8±60.2 U/l to 116±43.8 U/l). 25-Hydroxyvitamin D levels increased to 17.2±8.9 μg/l from 9.9±6.9 μg/l after CS treatment. The effects of recurrent use of CSs were assessed by dividing nephrotic patients into two subgroups: infrequent relapsers (IFR) and frequent relapsers (FR). The cumulative dose of CS was 28,125 mg/m2 for IFR and 105,000 mg/m2 for FR. The changes in OC, ALP, and 25-hydroxyvitamin D levels after CS treatment were significantly different between IFR and FR. We conclude that high-dose CS treatment causes a decrease in bone formation, as shown by the changes in OC and ALP levels. 25-Hydroxyvitamin D levels remained lower than control subjects after CS therapy. The higher the cumulative dose of CS used the more marked the changes in biochemical bone markers. The contribution of FR to baseline 25-hydroxyvitamin D levels needs further study.Keywords
This publication has 24 references indexed in Scilit:
- 25-Hydroxyvitamin D levels among healthy children in AlaskaThe Journal of Pediatrics, 2003
- Vitamin D status and secondary hyperparathyroidism: The importance of 25-hydroxyvitamin D cut-off levelsKidney International, 2003
- Glucocorticoid-induced osteoporosisEndocrinology and Metabolism Clinics of North America, 2003
- Changes in (markers of) bone metabolism during high dose corticosteroid pulse treatment in patients with rheumatoid arthritis.Annals of the Rheumatic Diseases, 1996
- Relationship of glucocorticoid dosage to serum bone gla‐protein concentration in patients with rheumatologic disordersArthritis & Rheumatism, 1990
- 1,25-Dihydroxyvitamin D-Responsive Element and Glucocorticoid Repression in the Osteocalcin GeneScience, 1989
- Calcium and vitamin D metabolism in children with nephrotic syndromeThe Journal of Pediatrics, 1986
- Measurements of γ-carboxyglutamate and circulating osteocalcin in normal children and adultsClinica Chimica Acta, 1983
- The estimation of vitamin D and its metabolites in human plasmaJournal of Steroid Biochemistry, 1981
- Effect of Prednisone on Growth and Bone Mineral Content in Childhood Glomerular DiseaseArchives of Pediatrics & Adolescent Medicine, 1978